Log inSign up
AAOIFI No. 21 screening

Is IOVA halal?

Iovance Biotherapeutics, Inc.

Halal

Iovance Biotherapeutics, Inc. passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 14 October 2026

Exchange

NASDAQ

Price

13.62

Day

-7.47%

Market cap

$6.59B

Industry

Biotechnology

Sector

Healthcare

What the company does

Iovance Biotherapeutics sells Amtagvi (a TIL cell therapy for melanoma made from the patient's own immune cells, approved 2024) and Proleukin. Its money comes from therapy sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ 36-month average market cap $1.88B = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $110.77M ÷ 36-month average market cap $1.88B = 5.9%

    5.9%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $10.31M ÷ annual revenue $263.50M (2025) = 3.9%

    3.9%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $6.59B.

For information (AAOIFI 3/1 note): cash + receivables are 41.5% of total assets (2025-12-31). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.01% · #511 of 1454

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyIOVA's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →